Crimean-Congo hemorrhagic fever: Strategies for diagnosis at initial admission

Ahmet Melih Şahin1, Emrullah Ataş1, Sinan Çetin1

  • 1Giresun University, Medical Faculty, Department of İnfectious Diseases and Clinical Microbiology, Giresun, Turkey.

Insights

Early diagnosis of Crimean-Congo Hemorrhagic Fever (CCHF) is crucial. This study identified key clinical and lab factors, including living in endemic areas, tick bites, and specific C-reactive protein (CRP) and procalcitonin (PCT) levels, to predict CCHF at initial presentation.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Clinical Diagnostics

Background:

  • Crimean-Congo Hemorrhagic Fever (CCHF) is a significant viral hemorrhagic fever with a broad differential diagnosis.
  • Accurate and timely diagnosis of CCHF is essential for appropriate patient management, including isolation and treatment protocols.

Purpose of the Study:

  • To develop a predictive model for CCHF diagnosis using clinical and laboratory findings at the time of initial patient presentation.
  • To identify independent risk factors and establish diagnostic cut-off values for CCHF.

Main Methods:

  • A comparative study involving 74 patients with confirmed CCHF and 43 patients with a preliminary CCHF diagnosis but ultimately negative.
  • Multivariate logistic regression and Receiver Operating Characteristics (ROC) curve analysis were employed to identify predictive variables.
  • Demographic, clinical, and laboratory data were analyzed.

Main Results:

  • Independent risk factors for CCHF diagnosis included residing in an endemic area, history of tick bite, fever, C-reactive protein (CRP) < 48 mg/L, and procalcitonin (PCT) < 0.52 ng/mL.
  • Specific cut-off values demonstrated high diagnostic accuracy: WBC 2485 mm³ (86% specificity), Neutrophil count 970 mm³ (93% specificity), CRP 48 mg/L (90.5% sensitivity), PCT 0.52 ng/mL (82.4% sensitivity).
  • Higher in-hospital and 28-day mortality rates were observed in the non-CCHF group.

Conclusions:

  • The study successfully identified key indicators for the early diagnosis of CCHF.
  • Utilizing easily accessible laboratory tests (WBC, neutrophil count, CRP, PCT) with established cut-off values can significantly aid in diagnosing CCHF upon initial presentation in endemic areas.
  • Accurate CCHF diagnosis facilitates prompt treatment and isolation, while also enabling earlier consideration of alternative diagnoses in non-CCHF patients, potentially improving outcomes for high-mortality conditions.